Medical News & Perspectives
November 28, 2001

Can a Common Medical Practice Transform Candida Infections From Benign to Deadly?

Author Affiliations

Not Available


Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001American Medical Association

Not Available

JAMA. 2001;286(20):2531-2532. doi:10.1001/jama.286.20.2531

San Francisco—New research hints that a common medical practice—the use of heparin in intravascular catheters to discourage blockages by blood clots—may sometimes inadvertently trigger events that transform a benign fungal infection into a deadly illness.

The microbe in question is Candida albicans, a yeast that often harmlessly colonizes patients. But C albicans has a darker side: it is also the leading cause of invasive fungal disease in premature infants and others with weakened immune systems, such as individuals infected with HIV, people recovering from surgery, and cancer or bone marrow transplantation patients.

First Page Preview View Large
First page PDF preview
First page PDF preview